Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Liberty Broadband Class C
LBRDK
$4.81B
| $788K | ﹤0.01% |
13,779
+1
| +0% | +$66 |
|
1777
John Wiley & Sons Class A
WLY
$2.63B
| $788K | ﹤0.01% |
20,659
-1
| -0% | -$34 |
|
1778
Astrana Health
ASTH
$1.72B
| $786K | ﹤0.01% |
18,748
+38
| +0.2% | +$1.48K |
|
1779
Oxford Industries
OXM
$565M
| $786K | ﹤0.01% |
6,998
-1
| -0% | -$101 |
|
1780
Virtu Financial
VIRT
$5.05B
| $784K | ﹤0.01% |
38,189
| – | – |
|
1781
DaVita
DVA
$15.2B
| $782K | ﹤0.01% |
5,670
| – | – |
|
1782
Hasbro
HAS
$13.4B
| $782K | ﹤0.01% |
13,832
-5,249
| -28% | -$267K |
|
1783
A.O. Smith
AOS
$8.16B
| $781K | ﹤0.01% |
8,730
-1,198
| -12% | -$98.8K |
|
1784
Newmark Group
NMRK
$2.63B
| $779K | ﹤0.01% |
70,360
-2
| -0% | -$21 |
|
1785
QuinStreet
QNST
$876M
| $778K | ﹤0.01% |
44,086
+21,502
| +95% | +$306K |
|
1786
Stewart Information Services
STC
$2.07B
| $774K | ﹤0.01% |
11,904
+1
| +0% | +$61 |
|
1787
Renasant Corp
RNST
$3.93B
| $774K | ﹤0.01% |
24,708
| – | – |
|
1788
National Vision
EYE
$1.78B
| $773K | ﹤0.01% |
34,891
+2
| +0% | +$42 |
|
1789
Schrodinger
SDGR
$1.13B
| $772K | ﹤0.01% |
28,616
| – | – |
|
1790
Opendoor
OPEN
$3.56B
| $768K | ﹤0.01% |
262,347
+136
| +0.1% | +$424 |
|
1791
Cannae Holdings
CNNE
$633M
| $768K | ﹤0.01% |
34,533
+1
| +0% | +$21 |
|
1792
Kymera Therapeutics
KYMR
$8.44B
| $766K | ﹤0.01% |
19,075
+19
| +0.1% | +$680 |
|
|
EGLE
1793
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $765K | ﹤0.01% |
12,248
-32
| -0.3% | -$1.87K |
|
1794
The GEO Group
GEO
$4.09B
| $764K | ﹤0.01% |
54,169
+3
| +0% | +$36 |
|
1795
EQT Corp
EQT
$32.8B
| $763K | ﹤0.01% |
20,592
-11,246
| -35% | -$403K |
|
|
HIBB
1796
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $760K | ﹤0.01% |
9,892
+73
| +0.7% | +$5.24K |
|
1797
Powell Industries
POWL
$7.67B
| $760K | ﹤0.01% |
16,041
| – | – |
|
1798
Snap
SNAP
$7.84B
| $760K | ﹤0.01% |
66,136
+14
| +0% | +$188 |
|
1799
Jazz Pharmaceuticals
JAZZ
$15.8B
| $756K | ﹤0.01% |
6,280
| – | – |
|
1800
The Greenbrier Companies
GBX
$1.52B
| $752K | ﹤0.01% |
14,450
-1
| -0% | -$48 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.